West Pharmaceutical Services (WST) Total Liabilities (2009 - 2026)

West Pharmaceutical Services has disclosed Total Liabilities across 18 years of filings, most recently posting $1.1 billion for Q1 2026.

• Total Liabilities for Q1 2026 came in at $1.1 billion, up 19.71% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.1 billion (up 19.71% YoY), and the FY2025 annual result was $1.1 billion, up 13.83% from the prior year.
• Total Liabilities came in at $1.1 billion for Q1 2026 at West Pharmaceutical Services, up from $1.1 billion in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $1.1 billion in Q1 2026 to a low of $846.0 million in Q3 2022.
• The 5-year median for Total Liabilities is $937.3 million (2022), against an average of $960.8 million.
• Across the five-year window, Total Liabilities dropped 10.03% in 2022 and increased 19.71% in 2026, its largest moves.
• West Pharmaceutical Services' Total Liabilities stood at $931.9 million in 2022, then climbed by 1.78% to $948.5 million in 2023, then gained by 1.33% to $961.1 million in 2024, then increased by 13.83% to $1.1 billion in 2025, then rose by 2.32% to $1.1 billion in 2026.
• The last three Total Liabilities figures came in at $1.1 billion (Q1 2026), $1.1 billion (Q4 2025), and $1.1 billion (Q3 2025), per Business Quant data.